Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Ketamine for Acute Traumatic Pain in the Emergency Department: A Prospective, Randomized Clinical Trial of Efficacy and Safety

NCT02817477 is registered in ClinicalTrials.gov with Tel Aviv Medical Center as lead sponsor.

NCT NCT02817477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02817477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Ketamine for Acute Traumatic Pain in the Emergency Department: A Prospective, Randomized Clinical Trial of Efficacy and Safety
Lead sponsor
Tel Aviv Medical Center
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2012
Completion date
April 30, 2014
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain